Two cons will hurt Health Catalyst over the next two years:
1. Health Catalyst's executives struggle to attack emerging and competitive markets with a timely, consistent, short- and long-term approach.
2. Health Catalyst cares more about their people than execution, often caring more about their people's concerns and feelings than strategic, client-oriented, or operational execution.
Executive management is improving on both of these cons and is focused on them. As listed in the pros, the grass is not greener at many competitors, but these two cons breed cyclical mediocrity on client-oriented execution and company competitiveness.
Finally, Health Catalyst is losing some of its mid-level talent. This is a symptom associated with the cons listed above.